While the mechanisms behind immune tolerance breakdown may vary, all Yo-PCD patients exhibited either Yo gene amplification/protein overexpression or mutation, suggesting that these alterations are sufficient to trigger Yo disorders [27]. This evidence concerns the gene CDR2 and paraneoplastic neurologic syndrome.